Warning: Stereotypes may be harmful to patients‘ health

How stereotypes hurt

 

Los Angeles, CA, USA (October 20, 2015) – The threat of facing stereotypes in the health care environment can mean poorer health outcomes for anyone with a stigmatized social identity, according to a new study led by USC Davis School Assistant Professor Cleopatra Abdou.A national study led by a USC researcher found people who encountered the threat of being judged by negative stereotypes related to weight, age, race, gender, or social class in health care settings reported adverse effects. The researchers found those people were more likely to have hypertension, to be depressed, and to rate their own health more poorly. They were also more distrustful of their doctors, felt dissatisfied with their care, and were less likely to use highly accessible preventive care, including the flu vaccine.


Health care stereotype threats stems from common stereotypes about unhealthy lifestyle choices or inferior intelligence that may be perpetuated, often unintentionally, by health care professionals or even by public health campaigns. Although health messages are intended to raise awareness of health issues or trends that may affect specific communities, one implication of this study is that these messages can backfire, said lead author Cleopatra Abdou, an assistant professor at the USC Davis School of Gerontology and Department of Psychology.

 

"An unintended byproduct of public health campaigns is that they often communicate and reinforce negative stereotypes about certain groups of people," Abdou said. "As a result, they may inadvertently increase experiences of what we call ‚healthcare stereotype threat,‘ which can affect health care efficacy and even prompt some patients to avoid care altogether."

 

As an example, Abdou cited campaigns about reproductive health in African American women and other women of color, sexual health in the LGBTQ community, depression among women, and memory problems in older adults. Such messages can reinforce and magnify the negative lens through which these groups of people are commonly viewed in society, she said.

 

"It’s not that there aren’t real health concerns in specific communities that we need to do more–much more–to address, but how we communicate about these concerns is key," Abdou said.

 

Abdou and her team surveyed an estimated 1,500 people as part of the U.S. Health and Retirement Study. More than 17 percent of the respondents said they felt vulnerable to prejudice with regard to racial or ethnic identity, gender, socio-economic status, weight or age in health care settings. People who felt threatened based on several identities were worse off, healthwise, than people who felt threatened based on just one identity.

 

Abdou said the challenge now is to find ways to inform all people, including people at heightened risk, about how to live healthier, happier, and longer lives while also minimizing the experience and effects of health care stereotype threat.

 

"It’s time for us to implement policies that enhance medical school training in cultural competency and increase the diversity of our physicians and broader health care workforce," Abdou said. "Hospitals and other health care institutions with inclusive policies which welcome diversity and celebrate tolerance, both symbolically and explicitly, hold great promise for reducing health care stereotype threat and the short- and long-term health disparities that we are now learning result from it."

 

 

 

The study was published online on Oct. 20 in the American Journal of Preventive Medicine. Study co-authors were Adam Fingerhut of Loyola Marymount University in Los Angeles, James Jackson of the University of Michigan, and Felicia Wheaton, also of the USC Davis School of Gerontology.

 

The research was funded by the National Institutes of Health, the Woodrow Wilson National Fellowship Foundation, and a Hanson-Thorell Family Research Award

 

 


University of Southern California, 20.10.2015 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…